share_log

HC Wainwright & Co. Maintains Buy on Biotricity, Lowers Price Target to $2

HC Wainwright & Co. Maintains Buy on Biotricity, Lowers Price Target to $2

HC Wainwright & Co.维持对Biotricity的买入,将目标价下调至2美元
Benzinga Real-time News ·  2022/07/15 06:24

HC Wainwright & Co. analyst Kevin Dede maintains Biotricity (NASDAQ:BTCY) with a Buy and lowers the price target from $6 to $2.

HC Wainwright & Co. 分析师凯文·德德维持Biotricity(纳斯达克股票代码:BTCY)的买入,并将目标股价从6美元下调至2美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发